Venetoclax-Rituximab in Chronic Lymphocytic Leukemia
- PMID: 29847898
- DOI: 10.1056/NEJMc1805135
Venetoclax-Rituximab in Chronic Lymphocytic Leukemia
Comment in
-
Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.N Engl J Med. 2018 May 31;378(22):2143-2144. doi: 10.1056/NEJMc1805135. N Engl J Med. 2018. PMID: 29847765 No abstract available.
Comment on
-
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.N Engl J Med. 2018 Mar 22;378(12):1107-1120. doi: 10.1056/NEJMoa1713976. N Engl J Med. 2018. PMID: 29562156 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources